149 related articles for article (PubMed ID: 38082520)
21. Analysis on the risk of myasthenia gravis related to immune checkpoint inhibitors based on the US FDA Adverse Event Reporting System.
Kong Q; Wang H; Ren X; Zhuo Y; Peng J
Cancer Med; 2023 Oct; 12(19):19491-19499. PubMed ID: 37724594
[TBL] [Abstract][Full Text] [Related]
22. Checkpoint-Inhibitor nun auch zur Therapie des metastasierten Merkelzellkarzinoms zugelassen.
Grabbe S; Terheyden P; Becker JC
J Dtsch Dermatol Ges; 2018 Mar; 16(3):394-395. PubMed ID: 29537164
[No Abstract] [Full Text] [Related]
23. Current status and future perspectives of immunotherapy against urothelial and kidney cancer.
Kobayashi T; Takeuchi A; Nishiyama H; Eto M
Jpn J Clin Oncol; 2021 Oct; 51(10):1481-1492. PubMed ID: 34389866
[TBL] [Abstract][Full Text] [Related]
24. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
Kaufman HL; Russell J; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Linette GP; Milella M; Brownell I; Lewis KD; Lorch JH; Chin K; Mahnke L; von Heydebreck A; Cuillerot JM; Nghiem P
Lancet Oncol; 2016 Oct; 17(10):1374-1385. PubMed ID: 27592805
[TBL] [Abstract][Full Text] [Related]
25. [Merkel-cell carcinoma].
Moll I
Pathologe; 2019 Dec; 40(Suppl 3):350-354. PubMed ID: 31820040
[TBL] [Abstract][Full Text] [Related]
26. S2k-Leitlinie zur Diagnostik und Therapie des Schleimhautpemphigoids.
Hofmann SC; Günther C; Böckle BC; Didona D; Ehrchen J; Gaskins M; Geerling G; Gläser R; Hadaschik E; Hampl M; Haßkamp P; Jackowski J; Kiritsi D; Nast A; Pleyer U; Reichel C; Roth M; Schumann M; Sticherling M; Worm M; Zillikens D; Goebeler M; Schmidt E
J Dtsch Dermatol Ges; 2022 Nov; 20(11):1530-1552. PubMed ID: 36383969
[TBL] [Abstract][Full Text] [Related]
27. S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus.
Ständer S; Zeidler C; Augustin M; Darsow U; Kremer AE; Legat FJ; Koschmieder S; Kupfer J; Mettang T; Metz M; Nast A; Raap U; Schneider G; Ständer H; Streit M; Schut C; Weisshaar E
J Dtsch Dermatol Ges; 2022 Oct; 20(10):1386-1402. PubMed ID: 36252075
[TBL] [Abstract][Full Text] [Related]
28. S3-Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms - Update 2015/2016, Kurzversion 2.0.
Eigentler TK; Mühlenbein C; Follmann M; Schadendorf D; Garbe C
J Dtsch Dermatol Ges; 2017 Jun; 15(6):e1-e41. PubMed ID: 28591444
[No Abstract] [Full Text] [Related]
29. Kutane Angiosarkome: molekulare Pathogenese und neue therapeutische Ansätze.
Goerdt LV; Schneider SW; Booken N
J Dtsch Dermatol Ges; 2022 Apr; 20(4):429-444. PubMed ID: 35446507
[TBL] [Abstract][Full Text] [Related]
30. Immune checkpoint inhibitors to treat cutaneous malignancies.
Barrios DM; Do MH; Phillips GS; Postow MA; Akaike T; Nghiem P; Lacouture ME
J Am Acad Dermatol; 2020 Nov; 83(5):1239-1253. PubMed ID: 32461079
[TBL] [Abstract][Full Text] [Related]
31. S2k-Leitlinie zur Diagnostik und Therapie des chronischen Pruritus - Update - Kurzversion.
Ständer S; Zeidler C; Augustin M; Bayer G; Kremer AE; Legat FJ; Maisel P; Mettang T; Metz M; Nast A; Niemeier V; Raap U; Schneider G; Ständer HF; Staubach P; Streit M; Weisshaar E
J Dtsch Dermatol Ges; 2017 Aug; 15(8):860-873. PubMed ID: 28763608
[No Abstract] [Full Text] [Related]
32. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
Colunga A; Pulliam T; Nghiem P
Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
[TBL] [Abstract][Full Text] [Related]
33. Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma.
Tun Min S; Nordman IIC; Tran HA
Case Rep Oncol; 2019; 12(2):639-643. PubMed ID: 31543781
[TBL] [Abstract][Full Text] [Related]
34. Positionspapier: Diagnostik und Therapie der Xerosis cutis.
Augustin M; Wilsmann-Theis D; Körber A; Kerscher M; Itschert G; Dippel M; Staubach P
J Dtsch Dermatol Ges; 2018 Jul; 16 Suppl 4():3-35. PubMed ID: 29989340
[TBL] [Abstract][Full Text] [Related]
35. Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.
Amaral T; Leiter U; Garbe C
Rev Endocr Metab Disord; 2017 Dec; 18(4):517-532. PubMed ID: 28916903
[TBL] [Abstract][Full Text] [Related]
36. [S2k-Leitlinie Diagnostik, Prävention und Therapie des Handekzems: S2k guideline diagnosis, prevention and therapy of hand eczema].
Bauer A; Brans R; Brehler R; Büttner M; Dickel H; Elsner P; Fartasch M; Herzog C; John SM; Köllner A; Maul JT; Merk H; Molin S; Nast A; Nikolakis GD; Schliemann S; Skudlik C; Weisshaar E; Werfel T; Zidane M; Worm M
J Dtsch Dermatol Ges; 2023 Sep; 21(9):1054-1076. PubMed ID: 37700403
[TBL] [Abstract][Full Text] [Related]
37. New perspectives in Merkel cell carcinoma.
Del Marmol V; Lebbé C
Curr Opin Oncol; 2019 Mar; 31(2):72-83. PubMed ID: 30694842
[TBL] [Abstract][Full Text] [Related]
38. Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid Cancers.
Al-Showbaki L; Nadler MB; Desnoyers A; Almugbel FA; Cescon DW; Amir E
J Cancer; 2021; 12(14):4372-4378. PubMed ID: 34093837
[No Abstract] [Full Text] [Related]
39. A Retrospective Study of Ipilimumab Plus Nivolumab in Anti-PD-L1/PD-1 Refractory Merkel Cell Carcinoma.
Shalhout SZ; Emerick KS; Kaufman HL; Silk AW; Thakuria M; Miller DM
J Immunother; 2022 Sep; 45(7):299-302. PubMed ID: 35877101
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.
D'Angelo SP; Russell J; Lebbé C; Chmielowski B; Gambichler T; Grob JJ; Kiecker F; Rabinowits G; Terheyden P; Zwiener I; Bajars M; Hennessy M; Kaufman HL
JAMA Oncol; 2018 Sep; 4(9):e180077. PubMed ID: 29566106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
